関連レポート

検眼機器の世界市場：製品タイプ別、用途別2029年予測

出版元：Transparency Market Research  出版元について

発行年：2024年4月

定価：Single User License $5795 Multi User License $8795 Corporate User License $11795

ご請求は円換算（お見積り日TTSレート）となります。

ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。

納品形態：PDF by Email

当調査レポートは英文 214ページになります。

商品コード：TMR258

当レポートは発行年月に関わらず、受注の都度、最新情報にアップデートしてお届けいたします。ご希望情報の追加等もご相談可能です。

レポート紹介

眼内薬物送達技術の世界市場規模は2023年で163億ドル、2034年に302億ドル、市場の平均年成長率は5.7%になると推測されます。

当レポートでは、眼内薬物送達技術の市場予測-2034年、各種セグメント別市場分析(技術別、製剤タイプ別、国地域別、等)、市場ダイナミクス、パイプライン分析、主要企業プロフィールなどの情報を盛り込み、概略以下の構成でお届けいたします。

【レポート構成概要】
■眼内薬物送達技術の世界市場予測2020-2034年
・市場規模(US$)

■技術別、市場-2034年
外用剤
眼用インサート
・侵食性
・非侵食性
イオントフォレーシス
眼内インプラント
・生分解性
・非生分解性
In Situゲル/涙点プラグ
その他
※(市場規模US$)

■製剤タイプ別、市場-2034年
溶液
懸濁液
エマルジョン
リポソーム/ナノ粒子
軟膏
※(市場規模US$)

■疾患タイプ別、市場-2034年
緑内障
黄斑変性症
糖尿病網膜症
白内障
糖尿病黄斑浮腫
ドライアイ症候群
その他
※(市場規模US$)

■エンドユーザー別、市場-2034年
病院
外来手術センター
眼科クリニック
在宅医療
※(市場規模US$)

■主要国地域別市場-2034年
北米
・米国、カナダ
欧州
・英国、ドイツ、フランス
・イタリア、スペイン
・その他欧州
アジア太平洋
・日本、中国、インド
・オーストラリア/ニュージーランド
・その他アジア太平洋
中東アフリカ
・GCC諸国、南アフリカ
・その他中東アフリカ
中南米
・ブラジル、メキシコ
・その他中南米
※地域別に各種セグメント別の細分化データ掲載、詳細は目次参照

■市場分析
市場ダイナミクス（ドライバー、阻害要因、機会）
パイプライン分析
主な買収合併
競合状況

■ 眼内薬物送達技術の主要企業プロフィール動向
Ocular Therapeutix, Inc.
Alimera Sciences Inc.
Allergan (an AbbVie company)
Bausch Health Companies Inc.
EyeGate Pharmaceuticals, Inc.
Envisia Therapeutics Inc.
Clearside Biomedical, Inc.
Graybug Vision, Inc.
参天製薬株式会社
Taiwan Liposome Company, Ltd.

（全214頁）

Table of Contents (英文詳細目次）

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Ocular Drug Delivery Technology Market

4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Ocular Drug Delivery Technology Market Analysis and Forecast, 2020-2034

5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry

6. Global Ocular Drug Delivery Technology Market Analysis and Forecast, by Technology
6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Technology, 2020-2034
6.3.1. Topical
6.3.2. Ocular Insert
6.3.2.1. Erodible
6.3.2.2. Non-erodible
6.3.3. Iontophoresis
6.3.4. Intraocular Implant
6.3.4.1. Biodegradable
6.3.4.2. Non-biodegradable
6.3.5. In Situ Gel & Punctal Plug
6.3.6. Others
6.4. Market Attractiveness, by Technology

7. Global Ocular Drug Delivery Technology Market Analysis and Forecast, by Formulation Type
7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Formulation Type, 2020-2034
7.3.1. Solution
7.3.2. Suspension
7.3.3. Emulsion
7.3.4. Liposome & Nanoparticle
7.3.5. Ointment
7.4. Market Attractiveness, by Formulation Type

8. Global Ocular Drug Delivery Technology Market Analysis and Forecast, by Disease Type
8.1. Introduction and Definitions
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Disease Type, 2020-2034
8.3.1. Glaucoma
8.3.2. Macular Degeneration
8.3.3. Diabetic Retinopathy
8.3.4. Cataract
8.3.5. Diabetic Macular Edema
8.3.6. Dry Eye Syndrome
8.3.7. Others
8.4. Market Attractiveness, by Disease Type

9. Global Ocular Drug Delivery Technology Market Analysis and Forecast, by End-user
9.1. Introduction and Definitions
9.2. Key Findings/Developments
9.3. Market Value Forecast, by End-user, 2020-2034
9.3.1. Hospitals
9.3.2. Ambulatory Surgical Centers
9.3.3. Ophthalmic Clinics
9.3.4. Homecare Settings
9.4. Market Attractiveness, by End-user

10. Global Ocular Drug Delivery Technology Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region, 2020-2034
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness, by Region

11. North America Ocular Drug Delivery Technology Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Technology, 2020-2034
11.2.1. Topical
11.2.2. Ocular Insert
11.2.2.1. Erodible
11.2.2.2. Non-erodible
11.2.3. Iontophoresis
11.2.4. Intraocular Implant
11.2.4.1. Biodegradable
11.2.4.2. Non-biodegradable
11.2.5. In Situ Gel & Punctal Plug
11.2.6. Others
11.3. Market Attractiveness, by Technology
11.4. Market Value Forecast, by Formulation Type, 2020-2034
11.4.1. Solution
11.4.2. Suspension
11.4.3. Emulsion
11.4.4. Liposome & Nanoparticle
11.4.5. Ointment
11.5. Market Attractiveness, by Formulation Type
11.6. Market Value Forecast, by Disease Type, 2020-2034
11.6.1. Glaucoma
11.6.2. Macular Degeneration
11.6.3. Diabetic Retinopathy
11.6.4. Cataract
11.6.5. Diabetic Macular Edema
11.6.6. Dry Eye Syndrome
11.6.7. Others
11.7. Market Attractiveness, by Disease Type
11.8. Market Value Forecast, by End-user, 2020-2034
11.8.1. Hospitals
11.8.2. Ambulatory Surgical Centers
11.8.3. Ophthalmic Clinics
11.8.4. Homecare Settings
11.9. Market Attractiveness, by End-user
11.10. Market Value Forecast, by Country, 2020-2034
11.10.1. U.S.
11.10.2. Canada
11.11. Market Attractiveness Analysis
11.11.1. By Technology
11.11.2. By Formulation Type
11.11.3. By Disease Type
11.11.4. By End-user
11.11.5. By Country

12. Europe Ocular Drug Delivery Technology Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Technology, 2020-2034
12.2.1. Topical
12.2.2. Ocular Insert
12.2.2.1. Erodible
12.2.2.2. Non-erodible
12.2.3. Iontophoresis
12.2.4. Intraocular Implant
12.2.4.1. Biodegradable
12.2.4.2. Non-biodegradable
12.2.5. In Situ Gel & Punctal Plug
12.2.6. Others
12.3. Market Attractiveness, by Technology
12.4. Market Value Forecast, by Formulation Type, 2020-2034
12.4.1. Solution
12.4.2. Suspension
12.4.3. Emulsion
12.4.4. Liposome & Nanoparticle
12.4.5. Ointment
12.5. Market Attractiveness, by Formulation Type
12.6. Market Value Forecast, by Disease Type, 2020-2034
12.6.1. Glaucoma
12.6.2. Macular Degeneration
12.6.3. Diabetic Retinopathy
12.6.4. Cataract
12.6.5. Diabetic Macular Edema
12.6.6. Dry Eye Syndrome
12.6.7. Others
12.7. Market Attractiveness, by Disease Type
12.8. Market Value Forecast, by End-user, 2020-2034
12.8.1. Hospitals
12.8.2. Ambulatory Surgical Centers
12.8.3. Ophthalmic Clinics
12.8.4. Homecare Settings
12.9. Market Attractiveness, by End-user
12.10. Market Value Forecast, by Country/Sub-region, 2020-2034
12.10.1. Germany
12.10.2. U.K.
12.10.3. France
12.10.4. Italy
12.10.5. Spain
12.10.6. Rest of Europe
12.11. Market Attractiveness Analysis
12.11.1. By Technology
12.11.2. By Formulation Type
12.11.3. By Disease Type
12.11.4. By End-user
12.11.5. By Country/Sub-region

13. Asia Pacific Ocular Drug Delivery Technology Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Technology, 2020-2034
13.2.1. Topical
13.2.2. Ocular Insert
13.2.2.1. Erodible
13.2.2.2. Non-erodible
13.2.3. Iontophoresis
13.2.4. Intraocular Implant
13.2.4.1. Biodegradable
13.2.4.2. Non-biodegradable
13.2.5. In Situ Gel & Punctal Plug
13.2.6. Others
13.3. Market Attractiveness, by Technology
13.4. Market Value Forecast, by Formulation Type, 2020-2034
13.4.1. Solution
13.4.2. Suspension
13.4.3. Emulsion
13.4.4. Liposome & Nanoparticle
13.4.5. Ointment
13.5. Market Attractiveness, by Formulation Type
13.6. Market Value Forecast, by Disease Type, 2020-2034
13.6.1. Glaucoma
13.6.2. Macular Degeneration
13.6.3. Diabetic Retinopathy
13.6.4. Cataract
13.6.5. Diabetic Macular Edema
13.6.6. Dry Eye Syndrome
13.6.7. Others
13.7. Market Attractiveness, by Disease Type
13.8. Market Value Forecast, by End-user, 2020-2034
13.8.1. Hospitals
13.8.2. Ambulatory Surgical Centers
13.8.3. Ophthalmic Clinics
13.8.4. Homecare Settings
13.9. Market Attractiveness, by End-user
13.10. Market Value Forecast, by Country/Sub-region, 2020-2034
13.10.1. China
13.10.2. Japan
13.10.3. India
13.10.4. Australia & New Zealand
13.10.5. Rest of Asia Pacific
13.11. Market Attractiveness Analysis
13.11.1. By Technology
13.11.2. By Formulation Type
13.11.3. By Disease Type
13.11.4. By End-user
13.11.5. By Country/Sub-region

14. Latin America Ocular Drug Delivery Technology Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Technology, 2020-2034
14.2.1. Topical
14.2.2. Ocular Insert
14.2.2.1. Erodible
14.2.2.2. Non-erodible
14.2.3. Iontophoresis
14.2.4. Intraocular Implant
14.2.4.1. Biodegradable
14.2.4.2. Non-biodegradable
14.2.5. In Situ Gel & Punctal Plug
14.2.6. Others
14.3. Market Attractiveness, by Technology
14.4. Market Value Forecast, by Formulation Type, 2020-2034
14.4.1. Solution
14.4.2. Suspension
14.4.3. Emulsion
14.4.4. Liposome & Nanoparticle
14.4.5. Ointment
14.5. Market Attractiveness, by Formulation Type
14.6. Market Value Forecast, by Disease Type, 2020-2034
14.6.1. Glaucoma
14.6.2. Macular Degeneration
14.6.3. Diabetic Retinopathy
14.6.4. Cataract
14.6.5. Diabetic Macular Edema
14.6.6. Dry Eye Syndrome
14.6.7. Others
14.7. Market Attractiveness, by Disease Type
14.8. Market Value Forecast, by End-user, 2020-2034
14.8.1. Hospitals
14.8.2. Ambulatory Surgical Centers
14.8.3. Ophthalmic Clinics
14.8.4. Homecare Settings
14.9. Market Attractiveness, by End-user
14.10. Market Value Forecast, by Country/Sub-region, 2020-2034
14.10.1. Brazil
14.10.2. Mexico
14.10.3. Rest of Latin America
14.11. Market Attractiveness Analysis
14.11.1. By Technology
14.11.2. By Formulation Type
14.11.3. By Disease Type
14.11.4. By End-user
14.11.5. By Country/Sub-region

15. Middle East & Africa Ocular Drug Delivery Technology Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Technology, 2020-2034
15.2.1. Topical
15.2.2. Ocular Insert
15.2.2.1. Erodible
15.2.2.2. Non-erodible
15.2.3. Iontophoresis
15.2.4. Intraocular Implant
15.2.4.1. Biodegradable
15.2.4.2. Non-biodegradable
15.2.5. In Situ Gel & Punctal Plug
15.2.6. Others
15.3. Market Attractiveness, by Technology
15.4. Market Value Forecast, by Formulation Type, 2020-2034
15.4.1. Solution
15.4.2. Suspension
15.4.3. Emulsion
15.4.4. Liposome & Nanoparticle
15.4.5. Ointment
15.5. Market Attractiveness, by Formulation Type
15.6. Market Value Forecast, by Disease Type, 2020-2034
15.6.1. Glaucoma
15.6.2. Macular Degeneration
15.6.3. Diabetic Retinopathy
15.6.4. Cataract
15.6.5. Diabetic Macular Edema
15.6.6. Dry Eye Syndrome
15.6.7. Others
15.7. Market Attractiveness, by Disease Type
15.8. Market Value Forecast, by End-user, 2020-2034
15.8.1. Hospitals
15.8.2. Ambulatory Surgical Centers
15.8.3. Ophthalmic Clinics
15.8.4. Homecare Settings
15.9. Market Attractiveness, by End-user
15.10. Market Value Forecast, by Country/Sub-region, 2020-2034
15.10.1. GCC Countries
15.10.2. South Africa
15.10.3. Rest of Middle East & Africa
15.11. Market Attractiveness Analysis
15.11.1. By Technology
15.11.2. By Formulation Type
15.11.3. By Disease Type
15.11.4. By End-user
15.11.5. By Country/Sub-region

16. Competition Landscape
16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
16.2. Market Share Analysis, by Company (2023)
16.3. Company Profiles
16.3.1. Ocular Therapeutix, Inc.
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. Alimera Sciences Inc.
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. Allergan (an AbbVie company)
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. Bausch Health Companies Inc.
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. EyeGate Pharmaceuticals, Inc.
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. Envisia Therapeutics Inc.
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. Clearside Biomedical, Inc.
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. Graybug Vision, Inc.
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
16.3.9. Santen Pharmaceutical Co., Ltd.
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. Financial Overview
16.3.9.4. SWOT Analysis
16.3.9.5. Strategic Overview
16.3.10. Taiwan Liposome Company, Ltd.
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Product Portfolio
16.3.10.3. Financial Overview
16.3.10.4. SWOT Analysis
16.3.10.5. Strategic Overview

List of Tables

Table 01: Global Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Technology, 2020-2034

Table 02: Global Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Formulation Type, 2020-2034

Table 03: Global Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by End-user, 2020-2034

Table 04: Global Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Disease Type, 2020-2034

Table 05: Global Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Region, 2020-2034

Table 06: North America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Country, 2020-2034

Table 07: North America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Technology, 2020-2034

Table 08: North America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Formulation Type, 2020-2034

Table 09: North America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Disease Type, 2020-2034

Table 10: North America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by End-user, 2020-2034

Table 11: Europe Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034

Table 12: Europe Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Technology, 2020-2034

Table 13: Europe Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Formulation Type, 2020-2034

Table 14: Europe Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Disease Type, 2020-2034

Table 15: Europe Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by End-user, 2020-2034

Table 16: Asia Pacific Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034

Table 17: Asia Pacific Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Technology, 2020-2034

Table 18: Asia Pacific Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Formulation Type, 2020-2034

Table 19: Asia Pacific Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Disease Type, 2020-2034

Table 20: Asia Pacific Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by End-user, 2020-2034

Table 21: Latin America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034

Table 22: Latin America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Technology, 2020-2034

Table 23: Latin America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Formulation Type, 2020-2034

Table 24: Latin America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Disease Type, 2020-2034

Table 25: Latin America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by End-user, 2020-2034

Table 26: Middle East & Africa Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034

Table 27: Middle East & Africa Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Technology, 2020-2034

Table 28: Middle East & Africa Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Formulation Type, 2020-2034

Table 29: Middle East & Africa Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Disease Type, 2020-2034

Table 30: Middle East & Africa Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by End-user, 2020-2034

List of Figures

Figure 01: Global Ocular Drug Delivery Technology Market Size (US$ Mn), by Region, 2023 and 2034

Figure 02: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn), by Technology, 2023

Figure 03: Global Ocular Drug Delivery Technology Market Value Share, by Technology, 2023

Figure 04: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn), by Formulation Type, 2023

Figure 05: Global Ocular Drug Delivery Technology Market Value Share, by Formulation Type, 2023

Figure 06: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn), by Disease Type, 2023

Figure 07: Global Ocular Drug Delivery Technology Market Value Share, by Disease Type, 2023

Figure 08: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn), by End-user, 2023

Figure 09: Global Ocular Drug Delivery Technology Market Value Share, by End-user, 2023

Figure 10: Global Ocular Drug Delivery Technology Market Value Share, by Region, 2023

Figure 11: Global Ocular Drug Delivery Technology Market Value (US$ Mn) Forecast, 2020-2034

Figure 12: Global Ocular Drug Delivery Technology Market Value Share Analysis, by Technology, 2023 and 2034

Figure 13: Global Ocular Drug Delivery Technology Market Attractiveness Analysis, by Technology, 2024-2034

Figure 14: Global Ocular Drug Delivery Technology Market Value Share Analysis, by Formulation Type, 2023 and 2034

Figure 15: Global Ocular Drug Delivery Technology Market Attractiveness Analysis, by Formulation Type, 2024-2034

Figure 16: Global Ocular Drug Delivery Technology Market Value Share Analysis, by Disease Type, 2023 and 2034

Figure 17: Global Ocular Drug Delivery Technology Market Attractiveness Analysis, by Disease Type, 2024-2034

Figure 18: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn), by End-user, 2023

Figure 19: Global Ocular Drug Delivery Technology Market Value Share, by End-user, 2023

Figure 20: Global Ocular Drug Delivery Technology Market Value Share Analysis, by Region, 2023 and 2034

Figure 21: Global Ocular Drug Delivery Technology Market Attractiveness Analysis, by Region, 2024-2034

Figure 22: North America Ocular Drug Delivery Technology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 23: North America Ocular Drug Delivery Technology Market Attractiveness Analysis, by Country, 2024-2034

Figure 24: North America Ocular Drug Delivery Technology Market Value Share Analysis, by Country, 2023 and 2034

Figure 25: North America Ocular Drug Delivery Technology Market Value Share Analysis, by Technology, 2023 and 2034

Figure 26: North America Ocular Drug Delivery Technology Market Value Share Analysis, by Formulation Type, 2023 and 2034

Figure 27: North America Ocular Drug Delivery Technology Market Value Share Analysis, by Disease Type, 2023 and 2034

Figure 28: North America Ocular Drug Delivery Technology Market Value Share Analysis, by End-user, 2023 and 2034

Figure 29: North America Ocular Drug Delivery Technology Market Attractiveness Analysis, by Technology, 2024-2034

Figure 30: North America Ocular Drug Delivery Technology Market Attractiveness Analysis, by Formulation Type, 2024-2034

Figure 31: North America Ocular Drug Delivery Technology Market Attractiveness Analysis, by Disease Type, 2024-2034

Figure 32: North America Ocular Drug Delivery Technology Market Attractiveness Analysis, by End-user, 2024-2034

Figure 33: Europe Ocular Drug Delivery Technology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 34: Europe Ocular Drug Delivery Technology Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 35: Europe Ocular Drug Delivery Technology Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 36: Europe Ocular Drug Delivery Technology Market Value Share Analysis, by Technology, 2023 and 2034

Figure 37: Europe Ocular Drug Delivery Technology Market Value Share Analysis, by Formulation Type, 2023 and 2034

Figure 38: Europe Ocular Drug Delivery Technology Market Value Share Analysis, by Disease Type, 2023 and 2034

Figure 39: Europe Ocular Drug Delivery Technology Market Value Share Analysis, by End-user, 2023 and 2034

Figure 40: Europe Ocular Drug Delivery Technology Market Attractiveness Analysis, by Technology, 2024-2034

Figure 41: Europe Ocular Drug Delivery Technology Market Attractiveness Analysis, by Formulation Type, 2024-2034

Figure 42: Europe Ocular Drug Delivery Technology Market Attractiveness Analysis, by Disease Type, 2024-2034

Figure 43: Europe Ocular Drug Delivery Technology Market Attractiveness Analysis, by End-user, 2024-2034

Figure 44: Asia Pacific Ocular Drug Delivery Technology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 45: Asia Pacific Ocular Drug Delivery Technology Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 46: Asia Pacific Ocular Drug Delivery Technology Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 47: Asia Pacific Ocular Drug Delivery Technology Market Value Share Analysis, by Technology, 2023 and 2034

Figure 48: Asia Pacific Ocular Drug Delivery Technology Market Value Share Analysis, by Formulation Type, 2023 and 2034

Figure 49: Asia Pacific Ocular Drug Delivery Technology Market Value Share Analysis, by Disease Type, 2023 and 2034

Figure 50: Asia Pacific Ocular Drug Delivery Technology Market Value Share Analysis, by End-user, 2023 and 2034

Figure 51: Asia Pacific Ocular Drug Delivery Technology Market Attractiveness Analysis, by Technology, 2024-2034

Figure 52: Asia Pacific Ocular Drug Delivery Technology Market Attractiveness Analysis, by Formulation Type, 2024-2034

Figure 53: Asia Pacific Ocular Drug Delivery Technology Market Attractiveness Analysis, by Disease Type, 2024-2034

Figure 54: Asia Pacific Ocular Drug Delivery Technology Market Attractiveness Analysis, by End-user, 2023-2034

Figure 55: Latin America Ocular Drug Delivery Technology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 56: Latin America Ocular Drug Delivery Technology Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 57: Latin America Ocular Drug Delivery Technology Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 58: Latin America Ocular Drug Delivery Technology Market Value Share Analysis, by Technology, 2023 and 2034

Figure 59: Latin America Ocular Drug Delivery Technology Market Value Share Analysis, by Formulation Type, 2023 and 2034

Figure 60: Latin America Ocular Drug Delivery Technology Market Value Share Analysis, by Disease Type, 2023 and 2034

Figure 61: Latin America Ocular Drug Delivery Technology Market Value Share Analysis, by End-user, 2023 and 2034

Figure 62: Latin America Ocular Drug Delivery Technology Market Attractiveness Analysis, by Technology, 2024-2034

Figure 63: Latin America Ocular Drug Delivery Technology Market Attractiveness Analysis, by Formulation Type, 2024-2034

Figure 64: Latin America Ocular Drug Delivery Technology Market Attractiveness Analysis, by Disease Type, 2024-2034

Figure 65: Latin America Ocular Drug Delivery Technology Market Attractiveness Analysis, by End-user, 2024-2034

Figure 66: Middle East & Africa Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 67: Middle East & Africa Ocular Drug Delivery Technology Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 68: Middle East & Africa Ocular Drug Delivery Technology Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 69: Middle East & Africa Ocular Drug Delivery Technology Market Value Share Analysis, by Technology, 2023 and 2034

Figure 70: Middle East & Africa Ocular Drug Delivery Technology Market Value Share Analysis, by Formulation Type, 2023 and 2034

Figure 71: Middle East & Africa Ocular Drug Delivery Technology Market Value Share Analysis, by Disease Type, 2023 and 2034

Figure 72: Middle East & Africa Ocular Drug Delivery Technology Market Value Share Analysis, by End-user, 2023 and 2034

Figure 73: Middle East & Africa Ocular Drug Delivery Technology Market Attractiveness Analysis, by Technology, 2024-2034

Figure 74: Middle East & Africa Ocular Drug Delivery Technology Market Attractiveness Analysis, by Formulation Type, 2024-2034

Figure 75: Middle East & Africa Ocular Drug Delivery Technology Market Attractiveness Analysis, by Disease Type, 2024-2034

Figure 76: Middle East & Africa Ocular Drug Delivery Technology Market Attractiveness Analysis, by End-user, 2024-2034

△ 一番上に戻る